Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Shares of Synthomer plc (LON:SYNT - Get Rating) have been given a consensus recommendation of "Hold" by the six ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is GBX 445.50 ($5.38).
A number of analysts have recently issued reports on the company. Berenberg Bank dropped their price target on Synthomer from GBX 350 ($4.23) to GBX 275 ($3.32) and set a "hold" rating for the company in a research report on Thursday, August 4th. Barclays reiterated an "equal weight" rating and set a GBX 323 ($3.90) price target on shares of Synthomer in a research report on Wednesday, August 3rd. Finally, JPMorgan Chase & Co. dropped their price target on Synthomer from GBX 430 ($5.20) to GBX 350 ($4.23) and set a "neutral" rating for the company in a research report on Wednesday, August 3rd.Synthomer Stock Up 0.8 %
Shares of LON SYNT opened at GBX 192.70 ($2.33) on Tuesday. Synthomer has a 52 week low of GBX 178.53 ($2.16) and a 52 week high of GBX 529 ($6.39). The business has a 50-day simple moving average of GBX 210.76 and a two-hundred day simple moving average of GBX 260.37. The company has a quick ratio of 0.97, a current ratio of 1.60 and a debt-to-equity ratio of 114.88. The company has a market cap of £900.56 million and a P/E ratio of 1,014.21. Synthomer Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Friday, November 4th. Investors of record on Thursday, October 6th will be issued a dividend of GBX 4 ($0.05) per share. The ex-dividend date of this dividend is Thursday, October 6th. This represents a dividend yield of 1.7%. Synthomer's dividend payout ratio is 157.89%. Insider Activity at Synthomer
In other news, insider Michael Willome acquired 70,000 shares of the firm's stock in a transaction that occurred on Thursday, August 4th. The shares were bought at an average cost of GBX 189 ($2.28) per share, with a total value of £132,300 ($159,859.84). In related news, insider Roberto Gualdoni purchased 20,000 shares of the firm's stock in a transaction on Tuesday, August 2nd. The shares were acquired at an average cost of GBX 214 ($2.59) per share, with a total value of £42,800 ($51,715.80). Also, insider Michael Willome purchased 70,000 shares of the firm's stock in a transaction on Thursday, August 4th. The stock was bought at an average cost of GBX 189 ($2.28) per share, for a total transaction of £132,300 ($159,859.84). In the last three months, insiders have bought 92,000 shares of company stock valued at $17,896,000. Synthomer Company Profile (Get Rating)
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.Recommended StoriesDarden Restaurants Takes the Low Road Against Inflation Why These 3 Stocks Are Off to Hot September StartsInflation Doesn’t Differentiate, But it’s Impact Does 3 Downgraded Must-Have Stocks To Put On Your WatchlistThis Is What To Expect From The Q3 Earnings Reporting Season
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
ETF portfolio manager, Dave Gilreath offers a perspective on “dividend achievers” and why these deserve a role in your portfolio
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.